Fred Alger Management’s Ascendis Pharma A/S ASND Stock Holding History

Fred Alger Management’s Portfolio ASND Stock Details ASND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$45.7M	Sell	171,447 -133,449	-44%	-$31.2M	0.15%	70
2026 Q1	$69.7M	Sell	304,896 -47,213	-13%	-$10.6M	0.31%	45
2025 Q4	$75.1M	Buy	352,109 +181,408	+106%	+$37.5M	0.29%	47
2025 Q3	$33.9M	Buy	170,701 +166,906	+4,398%	+$31.1M	0.13%	85
2025 Q2	$655K	Sell	3,795 -61,011	-94%	-$9.94M	﹤0.01%	377
2025 Q1	$10.1M	Sell	64,806 -47,048	-42%	-$6.72M	0.06%	171
2024 Q4	$15.4M	Sell	111,854 -146,356	-57%	-$19.2M	0.07%	154
2024 Q3	$38.6M	Sell	258,210 -48,863	-16%	-$6.6M	0.19%	89
2024 Q2	$41.9M	Buy	307,073 +120,952	+65%	+$16.5M	0.2%	84
2024 Q1	$28.1M	Sell	186,121 -7,381	-4%	-$1.05M	0.14%	120
2023 Q4	$24.4M	Sell	193,502 -76,503	-28%	-$7.63M	0.13%	131
2023 Q3	$25.3M	Sell	270,005 -81,006	-23%	-$7.58M	0.15%	132
2023 Q2	$31.3M	Buy	+351,011	New	+$30.5M	0.16%	134
2023 Q1	–	Sell	-14,556	Closed	-$1.78M	–	524
2022 Q4	$1.78M	Buy	+14,556	New	+$1.69M	0.01%	352
2020 Q3	–	Sell	-5,000	Closed	-$740K	–	466
2020 Q2	$740K	Hold	5,000	–	–	﹤0.01%	372
2020 Q1	$563K	Sell	5,000 -500	-9%	-$65K	﹤0.01%	352
2019 Q4	$765K	Sell	5,500 -1,500	-21%	-$167K	﹤0.01%	362
2019 Q3	$674K	Hold	7,000	–	–	﹤0.01%	360
2019 Q2	$806K	Sell	7,000 -1,500	-18%	-$179K	﹤0.01%	353
2019 Q1	$1M	Buy	+8,500	New	+$744K	﹤0.01%	333

Other funds holding ASND

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Fred Alger Management's ASND Position: Q2 2026 in Review

Fred Alger Management reduced its Ascendis Pharma A/S (ASND) stake by 44% in Q2 2026, selling an estimated $31.2M and leaving 171,447 shares worth $45.7M. The position accounts for 0.15% of the portfolio, ranked #70.

Fred Alger Management first reported a position in ASND in Q1 2019 and has held it in 20 quarters since. The position peaked at $75.1M in Q4 2025. 312 funds tracked by Wall St. Rank hold ASND as of Q2 2026.

Fred Alger Management held 171,447 shares of Ascendis Pharma A/S worth $45.7M as of Q2 2026.
Fred Alger Management sold 133,449 Ascendis Pharma A/S shares in Q2 2026, an estimated $31.2M.
Ascendis Pharma A/S made up 0.15% of Fred Alger Management's portfolio in Q2 2026, its #70 holding.
Fred Alger Management first reported a position in Ascendis Pharma A/S in Q1 2019 and has held it in 20 quarters since.
Fred Alger Management's Ascendis Pharma A/S position peaked at $75.1M in Q4 2025.
312 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q2 2026.

Based on Fred Alger Management's 13F filing for Q2 2026, filed 14 Aug 2026.